Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-227-6
CAS number: 12136-45-7
More severe effects, inflammatory lesions and gastric ulcers were seen
particularly in volunteers receiving the wax formulations. 60 to 70 % of
the volunteers treated with the wax-matrix KCl developed some type of
gastric lesions. The lesionswere graded from 0 (nomucosal damage) to 5
(severe mucosal damage. The mean score for the control group was 0.267,
and for the group receiving wax-matrix KCl 2.267.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Damit Sie die Website optimal nutzen können, verwenden wir Cookies.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again